Skip to Content

Me-PB-Hyos Elixir

Generic Name: phenobarbital, hyoscyamine sulfate, atropine sulfate and scopolamine hydrobromide
Dosage Form: oral liquid

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Me-PB-Hyos Elixir

Me-PB-Hyos Elixir
Rx only

Rev. 04/2014

DESCRIPTION:

Me-PB-Hyos Elixir - Grape:

Each 5 mL (teaspoonful) of elixir (alcohol not more than 23.8%) contains:

Phenobarbital, USP ................................................... 16.2 mg

Hyoscyamine Sulfate, USP ................................... 0.1037 mg

Atropine Sulfate, USP ........................................... 0.0194 mg

Scopolamine Hydrobromide, USP ......................... 0.0065 mg

INACTIVE INGREDIENTS:

Ethyl Alcohol, FD&C Blue #2, FD&C Red #40, Artificial Grape Flavor, Glycerin, Purified Water, Saccharin Sodium, Sorbitol, Sucrose.

CLINICAL PHARMACOLOGY:

This drug combination provides natural belladonna alkaloids in a specific, fixed ratio combined with phenobarbital to provide peripheral anticholinergic/ antispasmodic action and mild sedation.

INDICATIONS AND USAGE:

Based on a review of this drug by the National Academy of Sciences-National Research Council and/or other information, FDA has classified the following indications as “possibly” effective: For use as adjunctive therapy in the treatment of irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis. May also be useful as adjunctive therapy in the treatment of duodenal ulcer. IT HAS NOT BEEN SHOWN CONCLUSIVELY WHETHER ANTICHOLINERGIC/ ANTISPASMODIC DRUGS AID IN THE HEALING OF A DUODENAL ULCER, DECREASE THE RATE OF RECURRENCES OR PREVENT COMPLICATIONS.

CONTRAINDICATIONS:

Glaucoma, obstructive uropathy (for example, bladder neck obstruction due to prostatic hypertrophy); obstructive disease of the gastrointestinal tract (as in achalasia, pyloroduodenal stenosis, etc.); paralytic ileus, intestinal atony of the elderly or debilitated patient; unstable cardiovascular status in acute hemorrhage; severe ulcerative colitis especially if complicated by toxic megacolon; myasthenia gravis; hiatal hernia associated with reflux esophagitis. Me-PB-Hyos Elixir is contraindicated in patients with known hypersensitivity to any of the ingredients. Phenobarbital is contraindicated in acute intermittent porphyria and in those patients in whom phenobarbital produces restlessness and/or excitement.

WARNINGS:

In the presence of a high environmental temperature, heat prostration can occur with belladonna alkaloids (fever and heatstroke due to decreased sweating). Diarrhea may be an early symptom of incomplete intestinal obstruction, especially in patients with ileostomy or colostomy. In this instance, treatment with this drug would be inappropriate and possibly harmful.

Me-PB-Hyos Elixir may produce drowsiness or blurred vision. The patient should be warned, should these occur, not to engage in activities requiring mental alertness, such as operating a motor vehicle or other machinery, and not to perform hazardous work. Phenobarbital may decrease the effect of anticoagulants, and necessitate larger doses of the anticoagulant for optimal effect. When the phenobarbital is discontinued, the dose of the anticoagulant may have to be decreased. Phenobarbital may be habit forming and should not be administered to individuals known to be addiction prone or to those with a history of physical and/or psychological dependence upon drugs. Since barbiturates are metabolized in the liver, they should be used with caution and initial doses should be small in patients with hepatic dysfunction.

PRECAUTIONS:

GENERAL:

Use with caution in patients with: autonomic neuropathy, hepatic or renal disease, hyperthyroidism, coronary heart disease, congestive heart failure, cardiac arrhythmias, tachycardia, and hypertension. Belladonna alkaloids may produce a delay in gastric emptying (antral stasis) which would complicate the management of gastric ulcer. Do not rely on the use of the drug in the presence of complication of biliary tract disease. Theoretically, with overdosage, a curare-like action may occur.

CARCINOGENESIS, MUTAGENESIS, IMPAIRMENT OF FERTILITY:

Long-term studies in animals have not been performed to evaluate carcinogenic potential.

PREGNANCY:

PREGNANCY CATEGORY C

Animal reproduction studies have not been conducted with Me-PB-Hyos Elixir . It is not known whether Me-PB-Hyos Elixir can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Me-PB-Hyos Elixir should be given to a pregnant woman only if clearly needed.

NURSING MOTHERS.

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Me-PB-Hyos Elixir is administered to a nursing woman.

ADVERSE REACTIONS:

Adverse reactions may include xerostomia; urinary hesitancy and retention; blurred vision; tachycardia; palpitation; mydriasis; cycloplegia; increased ocular tension; loss of taste sense; headache; nervousness; drowsiness; weakness; dizziness; insomnia; nausea; vomiting; impotence; suppression of lactation; constipation; bloated feeling; musculoskeletal pain; severe allergic reaction or drug idiosyncrasies, including anaphylaxis, urticaria and other dermal manifestations; and decreased sweating. Elderly patients may react with symptoms of excitement, agitation, drowsiness, and other untoward manifestations to even small doses of the drug. Phenobarbital may produce excitement in some patients, rather than a sedative effect. In patients habituated to barbiturates, abrupt withdrawal may produce delirium or convulsions.

Adverse Events:

To report an adverse event, please contact Method Pharmaceuticals Customer Service at 1-877-250-3427.

OVERDOSAGE:

The signs and symptoms of overdose are headache, nausea, vomiting, blurred vision, dilated pupils, hot and dry skin, dizziness, dryness of the mouth, difficulty in swallowing, and CNS stimulation. Treatment should consist of gastric lavage, emetics, and activated charcoal. If indicated, parenteral cholinergic agents such as physostigmine or bethanechol chloride, should be used.

DOSAGE AND ADMINISTRATION:

The dosage of Me-PB-Hyos Elixir should be adjusted to the needs of the individual patient to assure symptomatic control with a minimum of adverse effects.

Adults: One or two teaspoonfuls of elixir three or four times a day according to conditions and severity of symptoms.

Pediatric patients: may be dosed every 4 to 6 hours.

   Starting Dosage
 Body weight              q4h  q6h
 10 lb. (4.5 kg)        0.5 mL  0.75 mL
 20 lb. (9.1 kg)              1.0 mL  1.5 mL
 30 lb. (13.6 kg)        1.5 mL  2.0 mL
 50 lb. (22.7 kg)        1/2 tsp  3/4 tsp
 75 lb. (34 kg)              3/4 tsp  1 tsp
 100 lb. (45.4 kg)        1 tsp 1  1/2 tsp

HOW SUPPLIED:

Me-PB-Hyos Elixir is a purple colored, grape flavored liquid.

1 Pint (473 mL) bottles - NDC 58657-420-16.

Store at controlled room temperature, 15-30°C (59-86°F). Protect from light and moisture.

Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. Use safety closures when dispensing this product unless otherwise directed by a physician or requested by purchaser.

Manufactured For:
Method Pharmaceuticals, LLC
Arlington, TX 76006

Rev. 04/2014


PRINCIPAL DISPLAY PANEL

NDC 58657-420-16
Me-PB-Hyos
Elixir
grape flavored
1 PINT

ME-PB-HYOS 
phenobarbital, hyoscyamine sulfate, atropine sulfate and scopolamine hydrobromide elixir
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:58657-420
Route of Administration ORAL DEA Schedule CIV    
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PHENOBARBITAL (PHENOBARBITAL) PHENOBARBITAL 16.2 mg  in 5 mL
HYOSCYAMINE SULFATE (HYOSCYAMINE) HYOSCYAMINE SULFATE 0.1037 mg  in 5 mL
ATROPINE SULFATE (ATROPINE) ATROPINE SULFATE 0.0194 mg  in 5 mL
SCOPOLAMINE HYDROBROMIDE (SCOPOLAMINE) SCOPOLAMINE HYDROBROMIDE 0.0065 mg  in 5 mL
Inactive Ingredients
Ingredient Name Strength
ALCOHOL  
FD&C BLUE NO. 2  
FD&C RED NO. 40  
GLYCERIN  
WATER  
SACCHARIN SODIUM  
SORBITOL  
SUCROSE  
Product Characteristics
Color PURPLE Score     
Shape Size
Flavor GRAPE Imprint Code
Contains         
Packaging
# Item Code Package Description
1 NDC:58657-420-16 473 mL in 1 BOTTLE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
UNAPPROVED DRUG OTHER 06/01/2014
Labeler - Method Pharmaceuticals, LLC (060216698)
Revised: 05/2014
 
Method Pharmaceuticals, LLC



More about Me-PB-Hyos (atropine / hyoscyamine / phenobarbital / scopolamine)

Professional resources

Related treatment guides

Hide